CULLINAN THERAPEUTICS INC (CGEM)

US2300311063 - Common Stock

19.25  +0.36 (+1.91%)

After market: 19.25 0 (0%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CGEM. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 26.86. This target is 39.53% above the current price.
CGEM was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CGEM.
In the previous month the buy percentage consensus was at a similar level.
CGEM was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 19.2519.1927.5426.8637.80 - -0.31% 43.06% 39.53% 96.36%
Up and Down Grades
Date Firm Action Rating
2024-04-17 JonesTrading Maintains Buy -> Buy
2024-04-17 BTIG Maintains Buy -> Buy
2024-04-16 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-15 William Blair Initiate Outperform
2024-03-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-15 Wedbush Initiate Outperform
2023-10-06 JonesTrading Initiate Buy
2023-08-11 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-09 HC Wainwright & Co. Reiterate Buy
2023-07-07 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-15 TD Cowen Initiate Outperform
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-26 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-12 HC Wainwright & Co. Maintains Buy -> Buy
2023-03-27 HC Wainwright & Co. Reiterate Buy
2023-03-10 HC Wainwright & Co. Reiterate Buy
2023-02-15 HC Wainwright & Co. Reiterate Buy
2023-02-03 Morgan Stanley Maintains Overweight
2022-11-21 BTIG Initiate Buy
2022-05-13 SVB Leerink Maintains Outperform
2021-06-07 Morgan Stanley Maintains Overweight
2021-06-04 SVB Leerink Maintains Outperform
2021-06-04 HC Wainwright & Co. Maintains Buy
2021-04-27 Morgan Stanley Upgrade Equal-Weight -> Overweight
2021-04-19 Morgan Stanley Maintains Equal-Weight
2021-03-30 HC Wainwright & Co. Maintains Buy